Reporting Adverse Events for Drugs, Devices, Biologics and D

FDA's Medwatch program allows health care professionals and consumers to report to the FDA serious problems with the medical products they prescribe, dispense, or use. These reports, along with follow-up investigations, can help to identify important safety concerns.

Take the example of the antibiotic Zyvox. Within the first six months of Zyvox's marketing, FDA began getting MedWatch reports of myelosupression from clinicians who suspected that the drug might be responsible. After investigating the problem, we worked with the manufacturer to change the Zyvox labeling to warn about the potential for myelosuppression.

Sometimes MedWatch reports highlight errors in prescribing or administering medications. For example, FDA received reports of patient injuries due to name confusion between LANOXIN, a heart medication, and what used to be called LEVOXINE, a thyroid medication. As a result, FDA asked the manufacturer to change the name of Levoxine, and now it's known as LEVOXYL, which is less likely to be confused with LANOXIN.

The MedWatch system can also help detect problems with medical products other than drugs. For example, FDA received two reports of pneumococcal eye infections in patients who'd received corneal transplants. An FDA inspection identified numerous manufacturing problems, which led the company to recall the implants.

Of course, MedWatch reports by themselves can not usually establish a causal relationship between an adverse event and a medical product - it may take a formal epidemiologic study to do that. Still, MedWatch reports are vital in making sure that medical products are safe, because they provide a rapid signal to FDA that problems may be occurring.

It is important to keep the MedWatch system working, and we can not do that without your help. Here are the kinds of reports we need from you:

• First of all, we are asking that you report any serious adverse event that might be associated with a drug, biologic, medical device, or dietary supplement. By "serious" we mean fatalities, hospitalizations, and medically significant events. We're especially interested in serious adverse events that aren't listed in the product labeling.

• Secondly, report therapeutic failures - cases where the drug or device failed to work as it should. For example, let us know if a patient has to switch from one brand of a drug to another because the original one was ineffective.

• Third, tell us about cases of use errors with medications or devices, including situations where the error may have been due to poor communication, or to ambiguities in product names, directions for use, or packaging.

• And finally, we would like to know about product quality issues, such as suspected counterfeit products, defective components, potential contamination, device malfunctions and poor packaging.

We encourage you to report these problems to MedWatch even if you are not sure that the product was the cause. It is easy to report by internet, phone, fax, or mail.

Additional Information:

MedWatch - The FDA Safety Information and Adverse Event Reporting System.
http://www.fda.gov/medwatch/

MedWatch: Managing Risks at the FDA. FDA Consumer Sept./Oct. 2003.
http://www.fda.gov/fdac/features/2003/503_risk.html

Category:

News & Politics

Tags:

• FDA
• Adverse
• Events
• Drugs
• Devices
• Biologics
• Dietary
• Supplements
• Metwatch

[OViewtubeO]

There is still name confusion surrounding the name Levoxyl. That med is one of the separate brands of the generic levothyroxine. But it sounds too much like the generic and so far two doctors and the pharmacy have mixed things up on me. I was originally told that if I go on a brand its important to stick to that brand for consistency - so this is an issue for me. Luckily, Im paying attention but feel for folks who may not be as alert (like the elderly).